CVS Health Corp (NY:CVS)

Walgreens agrees to pay $106.8 million to settle claims of false billing to federal health care programs. The settlement addresses fraudulent activities between 2009 and 2020 and includes significant...

Walgreens Agrees To $106.8M Settlement Over Alleged False Billing Claims ↗

September 16, 2024

Via Benzinga

Topics Lawsuit Whistleblower

3 Overlooked Stocks With Strong Value and Dividend Potential

September 13, 2024

Three forgotten-about, sluggishly performing defensive stocks that could offer value and income potential over the long term.

Via MarketBeat

PayPal Is A Buy, Jim Cramer Says: As For Rivian? 'Let It Percolate' ↗

September 12, 2024

PayPal will become an additional credit and debit card processor for Shopify Payments through its PayPal Complete Payments solution.

Via Benzinga

Behind the Scenes of CVS Health's Latest Options Trends ↗

September 11, 2024

Via Benzinga

What 9 Analyst Ratings Have To Say About CVS Health ↗

September 10, 2024

Via Benzinga

UnitedHealth Follows Competitors, Replaces Humira with Lower-Cost Biosimilars ↗

September 11, 2024

UnitedHealth will remove AbbVie's Humira from its preferred drug lists by 2025, opting for lower-cost biosimilars like Amgen's Amjevita, in a move aimed at cutting prescription costs.

Via Benzinga

CVS Shares Are Trading Lower Wednesday: What You Need To Know ↗

September 11, 2024

CVS Health Corporation (NYSE: CVS) shares are seeing a The sell-off comes in the wake of the recent Trump-Harris debate, which has created a wave of uncertainty in the healthcare sector. Here's what...

Via Benzinga

Interest Rates, Private Equity, Stocks, Football...We've Got It All ↗

September 11, 2024

Including an interview with former NFL linebacker Brandon Copeland.

Teva Announces $80M Settlement To Baltimore: City Continues Opioid Litigation Against Other Companies ↗

September 10, 2024

Baltimore secures an $80 million settlement with Teva Pharmaceuticals in its opioid crisis litigation. Funds will be allocated to education, recovery centers, and outreach initiatives.

Via Benzinga

CVS Health's Options: A Look at What the Big Money is Thinking ↗

September 09, 2024

Via Benzinga

What the Options Market Tells Us About CVS Health ↗

September 05, 2024

Via Benzinga

Peering Into CVS Health's Recent Short Interest ↗

September 04, 2024

Via Benzinga

CVS Investors Have Opportunity to Join CVS Health Corporation Fraud Investigation with the Schall Law Firm

September 10, 2024

From The Schall Law Firm

CVS Investors Have Opportunity to Lead CVS Health Corporation Securities Fraud Lawsuit With the Schall Law Firm

September 09, 2024

From The Schall Law Firm

The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against CVS Health Corporation (CVS)

September 09, 2024

From The Law Offices of Frank R. Cruz

CVS DEADLINE: ROSEN, A LEADING LAW FIRM, Encourages CVS Health Corporation Investors to Secure Counsel Before Important September 10 Deadline in Securities Class Action – CVS

This Is What Whales Are Betting On CVS Health ↗

August 29, 2024

Via Benzinga

September 09, 2024

From The Rosen Law Firm PA

Rosen Law Firm Encourages CVS Health Corporation Investors to Secure Counsel Before Important September 10 Deadline in Securities Class Action with an Expanded Class Period– CVS

September 06, 2024

From The Rosen Law Firm, P.A.

Wall Street's Most Accurate Analysts Weigh In On 3 Health Care Stocks With Over 3% Dividend Yields ↗

September 06, 2024

Via Benzinga

Got $5,000? These 3 High-Yielding Dividend Stocks Are Trading Near Their 52-Week Lows ↗

September 06, 2024

These stocks offer above-average yields ranging between 2.8% and 5.1%.

CVS DEADLINE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages CVS Health Corporation Investors to Secure Counsel Before Important September 10 Deadline in Securities Class Action – CVS

September 05, 2024

From The Rosen Law Firm PA

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against CVS, Walgreens, Vicor, and American Airlines and Encourages Investors to Contact the Firm

September 03, 2024

From Bragar Eagel & Squire

Shares of the dividend-paying pharmacy chain have been offering a double-digit yield percentage.

10 Health Care Stocks With Whale Alerts In Today's Session ↗

September 03, 2024

Via Benzinga

Down About 65% in 2024, Is Walgreens Stock a Buy on the Dip? ↗

September 03, 2024

CVS HEALTH CORPORATION (NYSE: CVS) DEADLINE ALERT: Bernstein Liebhard LLP Reminds CVS Health Corporation Investors of Upcoming Deadline

September 03, 2024

From Bernstein Liebhard LLP

These stocks have been dealing with some ire from investors.

2 Magnificent Stocks to Buy That Are Near 52-Week Lows ↗

September 02, 2024

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against CVS, Walgreens, SeaStar, and Bolt and Encourages Investors to Contact the Firm

August 30, 2024

From Bragar Eagel & Squire

Two weeks ago we turned to a more bullish stance, which has proved to be correct, though we still await the explosive movement out of these consolidations.

Patchy But Still Bullish ↗

September 02, 2024

Via Talk Markets

CVS Stock: Low Multiple, High Dividend. What Could Possibly Go Wrong? ↗

August 28, 2024

Chasing yield without conducting proper due diligence could be bad for your financial health.